E I Du Pont De Nemours And Co  

(Public, NYSE:DD)   Watch this stock  
Find more results for DD
-0.12 (-0.18%)
Real-time:   12:35PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 66.84 - 67.47
52 week 47.43 - 75.72
Open 67.09
Vol / Avg. 439,781.00/2.79M
Mkt cap 58.58B
P/E 27.53
Div/yield 0.38/2.27
EPS 2.44
Shares 874.32M
Beta 1.82
Inst. own 72%
Oct 25, 2016
Q3 2016 E I du Pont de Nemours and Co Earnings Release - 9:30AM EDT - Add to calendar
Oct 25, 2016
Q3 2016 E I du Pont de Nemours and Co Earnings Call - 8:00AM EDT - Add to calendar
Jul 26, 2016
Q2 2016 E I du Pont de Nemours and Co Earnings Release
Jul 26, 2016
Q2 2016 E I du Pont de Nemours and Co Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 14.50% 7.50%
Operating margin 19.51% 9.30%
EBITD margin - 17.80%
Return on average assets 9.80% 4.14%
Return on average equity 40.41% 16.45%
Employees 52,000 -
CDP Score - 99 B


974 Centre Rd
WILMINGTON, DE 19805-1269
United States - Map
+1-302-7741000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment. It is also involved in other businesses, such as pre-commercial programs, nonaligned businesses and pharmaceuticals in other.

Officers and directors

Edward D. Breen Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Nicholas Charles Fanandakis Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
James C. Collins Jr. Executive Vice President
Age: 53
Bio & Compensation  - Reuters
C. Marc Doyle Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Stacy L. Fox Senior Vice President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Benito Cachinero-Sanchez Senior Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Douglas W. Muzyka Senior Vice President and Chief Science & Technology Officer
Age: 61
Bio & Compensation  - Reuters
Lamberto Andreotti Independent Director
Age: 65
Bio & Compensation  - Reuters
Robert A. Brown Independent Director
Age: 64
Bio & Compensation  - Reuters
Alexander M. Cutler Independent Director
Age: 64
Bio & Compensation  - Reuters